Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2023-06-20 | 2023-06-27 | 195861 |
PENICILLIN G SODIUM FOR INJECTION, USP | 10000000UNIT | POWDER FOR SOLUTION | Actual shortage | 2017-03-13 | 2020-02-13 | 1772 |
PENICILLIN G SODIUM FOR INJECTION, USP | 1000000UNIT | POWDER FOR SOLUTION | Actual shortage | 2017-03-13 | 2020-02-13 | 1764 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-13 | 2020-02-13 | 1739 |
TEVA-NYSTATIN | 100000UNIT | DROPS | Resolved | 2017-03-14 | 2018-03-08 | 2410 |
RATIO-NYSTATIN | 100000UNIT | OINTMENT | Resolved | 2017-03-17 | 2017-09-05 | 3145 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-17 | 2017-04-25 | 3148 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92678 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92681 |
TEVA-NYSTATIN | 100000UNIT | CREAM | Resolved | 2020-01-24 | 2020-07-10 | 104336 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-01-30 | 2020-12-03 | 104914 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-02-13 | 2020-04-09 | 106018 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-04-23 | 2020-11-26 | 113034 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-01-20 | 2022-03-24 | 153141 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-10-28 | 2022-12-15 | 173052 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-06-19 | 2023-07-14 | 195501 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-07-27 | 2023-08-04 | 200231 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-08-17 | 2023-12-14 | 202239 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-11-30 | 2024-01-11 | 211976 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Actual shortage | 2024-02-08 | 2024-04-18 | 218952 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |